Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07203261 · ClinicalTrials.gov registry record
Comparison of the Body Roundness Index and A Body Shape Index With Body Fat and Visceral Fat in People Living With HIV.
A clinical trial, sponsored by Queens College, The City University of New York.
- Not yet
- Registry status
- 65
- Enrollment target
NCT07203261: Clinical Trial study, sponsored by Queens College, The City University of New York.
NCT07203261 is a clinical trial that has not yet begun recruiting, run by Queens College, The City University of New York. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07203261 has not yet begun recruiting, sponsored by Queens College, The City University of New York.
- NOT YET RECRUITING
- Registry status
- 65 participants
- Enrollment target
Study Summary
The study compares the Body Roundness Index (BRI) and the A Body Shape Index (ABSI) with with body fat and visceral fat in people living with HIV.
Primary Outcome
The ABSI is a measure of the body shape and the concentration of body volume. The ABSI is defined as the waist circumference (WC) divided by the body mass index (BMI) raised to two-thirds and by the square root of the person's height. WC will be measured just above the uppermost lateral border of the ilium at the end of a normal exhalation as recommended by NHANES guidelines. BMI will be calculated as Weight (kilograms) / Height (meters)2. Height will be measured using a standard stadiometer. Wi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2025-09-25 |
| Est. Completion | 2026-12-31 |
What is known before NCT07203261 opens enrollment
NCT07203261 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT07203261 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07203261 about?
NCT07203261 is a clinical study titled "Comparison of the Body Roundness Index and A Body Shape Index With Body Fat and Visceral Fat in People Living With HIV.". The study compares the Body Roundness Index (BRI) and the A Body Shape Index (ABSI) with with body fat and visceral fat in people living with HIV.
What is the current status of trial NCT07203261?
This trial is currently not yet recruiting. The enrollment target is 65 participants. The study started on 2025-09-25. Estimated completion is 2026-12-31.
Who is sponsoring clinical trial NCT07203261?
This trial is sponsored by Queens College, The City University of New York, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI